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Abstract
Accurately assessing a patient’s risk of a given event is essential in making informed
treatment decisions. One approach is to stratify patients into two or more distinct risk
groups with respect to a specific outcome using both clinical and demographic variables.
Outcomes may be categorical or continuous in nature; important examples in cancer stud-
ies might include level of toxicity or time to recurrence. Recursive partitioning methods
are ideal for building such risk groups. Two such methods are Classification and Re-
gression Trees (CART) and a more recent competitor known as the partitioning Dele-
tion/Substitution/Addition (partDSA) algorithm, both which also utilize loss functions (e.g.
squared error for a continuous outcome) as the basis for building, selecting and assessing
predictors but differ in the manner by which regression trees are constructed.
Recently, we have shown that partDSA often outperforms CART in so-called “full data”
(e.g., uncensored) settings. However, when confronted with censored outcome data, the loss
functions used by both procedures must be modified. There have been several attempts to
adapt CART for right-censored data. This article describes two such extensions for partDSA
that make use of observed data (i.e. possibly censored) loss functions. These observed data
loss functions, constructed using inverse probability of censoring weights, are consistent es-
timates of their uncensored counterparts provided that the corresponding censoring model
is correctly specified. The relative performance of these new methods is evaluated via sim-
ulation studies and illustrated through an analysis of clinical trial data on brain cancer
patients. The implementation of partDSA for uncensored and right censored outcomes is
publicly available in the R package, partDSA.
1 Introduction
Clinicians carefully weigh a patient’s prognosis when deciding on the aggressiveness of treat-
ment. In determining a patient’s prognosis, clinicians may consider a patient’s age, gender,
clinical information and, more recently, biological variables such as gene or protein expression.
Objective guidelines for predicting a patient’s prognosis (i.e., risk) from clinical and biological
information can be obtained from risk indices estimated from data collected on an independent
sample of patients with known covariates and outcome. Frequently, the outcome of interest
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is the time to occurrence of a specified event; common examples in cancer include death and
recurrence or progression of disease. The use of time-to-event outcomes frequently results in
the presence of right-censored outcome data on several patients.
There are many statistical learning methods that might be used in building predictors
of risk for a given outcome using covariate information. An attractive class of methods for
building clinically interpretable risk indices is recursive partitioning methods. The Classification
and Regression Tree algorithm (CART; Breiman et al., 1984) is perhaps the most well-known
recursive partitioning method. Left unchecked, CART has the capability of placing each subject
in his own terminal node. An important consideration therefore lies in the selection of an
appropriate number of splits (i.e., nodes). This “pruning” problem involves an inherent but
familiar trade-off: construct an accurate estimator that also avoids overfitting the model to
the data. CART uses cross-validation in combination with a specified loss function in order to
determine where to stop partitioning the covariate space. In the resulting pruned tree, a single
predicted value is assigned to each terminal node. For example, with a continuous outcome and
an L2 (i.e., squared-error) loss function, the predicted value for each terminal node is the mean
outcome for all observations falling into that node.
Molinaro et al. (2010) recently developed partDSA, a new loss-based recursive partitioning
method. Like CART, partDSA divides the covariate space into mutually exclusive and disjoint
regions on the basis of a chosen loss function. The resulting regression models continue to
take the form of a decision tree; hence, partDSA also provides an excellent foundation for
developing a clinician-friendly tool for accurate risk prediction and stratification. However, this
algorithm differs from CART in that the decision tree may be constructed from both ‘and’ and
‘or’ conjunctions of predictors. The advantage of this representation is two-fold: (i) in cases
where only ’and’ conjunctions of predictors are required to build a parsimonious model, the
partDSA and CART representations coincide; and, (ii) in cases where CART requires two or
more terminal nodes to represent distinct subpopulations (i.e., defined by covariates) having
the same outcome distribution, partDSA can represent these same structures using a single
partition. Molinaro et al. (2010) showed that this increased flexibility improves prediction
accuracy and predictor stability for uncensored continuous outcomes using a L2 loss function
in comparison to the best adaptive algorithms in the statistical literature, including CART and
Logic Regression (Ruczinski et al., 2003).
In both CART and partDSA, the choice of loss function plays a key role in each step of
the model building process. The default choice for continuous outcomes (i.e., L2 loss) requires
modification if these outcomes are censored. Numerous adaptations of CART have been sug-
gested in the literature for handling right-censored outcomes; see, for example, Gordon and
Olshen (1985), Ciampi et al. (1986), Segal (1988) Therneau et al. (1990), LeBlanc and Crowley
(1992), and LeBlanc and Crowley (1993). With one exception, each of the aforementioned
adaptations of CART replaces the usual L2 loss function with a criterion function that relies on
more traditional estimators and measures of fit used with right censored outcome data. In the
absence of censoring, such adaptations typically yield answers that differ from those provided
by the default implementation of CART. Adaptations that replace the L2 loss function with
other criteria also do not allow one to easily quantify the prediction error of the final model
using the same loss function. Molinaro et al. (2004) proposed CARTIPCW , a direct adaptation
of CART that replaces the L2 loss function with an Inverse Probability Censoring Weighted
estimator (IPCW; Robins and Rotnitzky, 1992) of the desired “full data” L2 loss function (i.e.,
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that which would be used in the absence of censoring). This allows for an otherwise unaltered
implementation of CART to be used for splitting, pruning, and estimation. The IPCW-L2 loss
function, computable for observed data, is under standard assumptions a consistent estimator
of the full data L2 loss function. Molinaro et al. (2004) demonstrate that CARTIPCW generally
has lower prediction error, measured as L1 loss using the Kaplan Meier median as the predicted
value within a given node, when compared to the one-step deviance method of LeBlanc and
Crowley (1992).
In this paper, we similarly extend partDSA to the setting of right-censored data using a
IPCW-L2 loss function. The resulting methodology builds a decision tree based on the (time-
restricted) mean response in each node. We also extend partDSA to the problem of predicting a
binary outcome of the form Z(t) = I(T ≥ t), where T is the event time of interest and t is some
specified time point. This extension involves a weighted modification of the L2 loss function
that uses the Brier Score (Graf et al., 1999). Graf et al. (1999) introduces this measure as a
way to compare the predictive accuracy of various estimators of survival experience. Two novel
contributions of this paper are to (i) demonstrate that this score has a simple but interesting
representation as an IPCW-weighted L2 function; and, (ii) make use of this loss function as the
basis for constructing a partDSA regression tree.
The remainder of this paper proceeds as follows. First, we describe the relevant “full data”
and “observed data” structures, giving a brief overview of loss-based estimation in each setting.
We then discuss how these ideas may be used to extend the partDSA algorithm to right-censored
outcomes. The performance of these extensions of partDSA are evaluated via simulations and
in an analysis of clinical trial data on brain cancer patients. Finally, we close the paper with a
discussion and comments on further, useful extensions.
2 Methods
2.1 Relevant Data Structures
2.1.1 Full Data
In the ideal setting, one observes n i.i.d. observations X1, . . . , Xn, of a “full data” structure,
say X = (T,W ), where T denotes a response variable and W ∈ S denotes a (possibly high-
dimensional) vector of covariates. Denote the corresponding (unknown) distribution of X by
FX,0. With time-to-event data, our focus hereafter, T > 0 is a continuous random variable
that denotes the event time of interest and W represents a set of baseline covariates. In this
case, we may equivalently define the full data as X = (Z,W ), where Z = log T . In the
setting of cancer risk prediction, W may include age as well as various genomic, epidemiologic
and histologic measurements that are continuous or categorical in nature. More generally, the
available information may include both time-dependent and time-independent covariates; we
focus on the setting of time-independent W only.
2.1.2 Observed Data
In practice, information may be missing on one or more of the Xis; that is, one instead observes
n i.i.d. observations O1, . . . , On of an observed data structure O having distribution FObs. With
time-to-event outcomes, the most common form of missing data is right-censoring of event times
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due to drop out or end of follow-up. Here, O = {T˜ = min(T,C),∆ = I(T ≤ C),W}, where
T˜ = min(T,C) and ∆ = I(T ≤ C); equivalently, O = (Z˜,∆, X), where Z˜ = log T˜ . The
distribution FObs of O then depends on FX,0 and the conditional distribution of the censoring
variable C given X, say G0(·|X).
We assume that the censoring variable C is conditionally independent of T given W ; that is,
G¯0(·|X) = G¯0(·|W ), where G¯0(c | X) = Pr(C ≥ c | X) and G¯0(c | W ) is defined analogously.
Since X includes only time-independent covariates, it therefore satisfies a coarsening at random
condition (CAR) (Gill et al., 1997). In the absence of CAR, fully-specified parametric models
for the dependence of G¯0(·|X) on T (or Z) are needed and may be used in combination with
sensitivity analysis (e.g., Scharfstein and Robins, 2002).
2.2 Loss-Based Estimation
2.2.1 Estimation with Full Data
Let ψ : S → R be a real-valued function of W , where ψ ∈ Ψ. Let L(X,ψ) denote a full data
loss function and define EFX,0{L(X,ψ)} =
∫
L(x, ψ)dFX,0(x) as the corresponding risk of ψ.
The parameter of interest, ψ0, is then defined as a minimizer of the risk EFX,0{L(X,ψ0)} =
min
ψ∈Ψ
EFX,0{L(X,ψ)}. In practice, and on the basis of the fully observed data X1, . . . , Xn, ψ0 can
be estimated by minimizing the empirical risk (i.e., average loss) n−1
∑n
i=1 L(Xi, ψ). Generally
speaking, feasible estimation procedures require ψ(·) to be modeled in some fashion, in which
case estimation of ψ0 reduces to estimating the corresponding model parameter(s). We reserve
further discussion of this issue until Section 2.4, where piecewise constant regression estimators
will be of primary interest in connection with partDSA.
The purpose of the loss function is to quantify a specific measure of performance and,
depending on the parameter of interest, there could be numerous loss functions from which
to choose. In the case of the continuous outcome Z = log T , the conditional mean ψ0(W ) =
E(Z | W ) is frequently of interest. Under mild conditions, ψ0(W ) is the unique minimizer of
the risk under the squared error loss L(X,ψ) = {Z − ψ(W )}2. However, it also minimizes the
risk under the much larger class of Bregman loss functions (e.g., Banerjee et al., 2005), with
the corresponding optimal risk measuring other aspects of performance.
In the case of time-to-event data, median survival and estimated survivorship proba-
bilities are often of interest. It is easily shown that the conditional median survival time
ψ0(W ) = Med(T |W ) minimizes the risk under the absolute error loss L(X,ψ) =| T −ψ(W ) |.
Survivorship estimation can also be viewed as a loss minimization problem. For example, let
Z(t) = I(T > t) denote survival status at a given time t. Then, the predictor ψt(W ) minimizing
the risk under L(X, ψ˜t) = {Z(t) − ψ˜t(W )}2 is ψ0t(W ) = P (T > t|W ) (e.g. Graf et al., 1999).
Minimizing the corresponding average loss yields an estimator for ψ0t(W ).
2.2.2 Estimation with Observed Data
In the presence of right-censored outcome data, the goal remains to find an estimator for a
parameter ψ0 that is defined in terms of the risk for a full data loss function L(X,ψ), e.g., a
predictor of the log survival time Z based on covariates W . An immediate problem is that
L(X,ψ) cannot be evaluated for any observation O having a censored survival time (∆ = 0);
for example, L(X,ψ) = {Z − ψ(W )}2 cannot be evaluated if Z = log T is not observed. Risk
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estimators based on only uncensored observations, such as n−1
∑
i L(Xi, ψ)∆i, are biased esti-
mators for EFX,0{L(X,ψ)}. Replacing the full (uncensored) data loss function by an observed
(censored) data loss function having the same risk provides one possible solution to this problem.
IPCW estimators with right-censored outcomes were introduced in Robins and Rotnitzky
(1992). Though most frequently used in the development of unbiased observed data estimating
equations, the IPCW principle is valid in great generality and can be used to solve the desired
risk estimation problem. Assume EFObs(∆|X) = G¯0(T |W ) > 0, where G¯0(c | W ) = Pr(C ≥
c | W ); see Section 2.1.2. Then, EFObs{∆L(X,ψ)/G¯0(T | W )} = EFX,0{L(X,ψ)}, implying
that n−1
∑n
i=1 ∆iL(Xi, ψ)/G¯0(Ti | Wi) is an unbiased estimator of the desired full data risk
EFX,0{L(X,ψ)}. A simple but important example is the IPCW version of the L2 loss function,
given by the previous formula with L(Xi, ψ) = {Zi − ψ(Wi)}2.
In general, the censoring probability function G¯0(·|W ) is unknown and must be estimated
from the data. For any consistent estimator G¯n(·|W ) of G¯0(·|W ),
1
n
n∑
i=1
L(Xi, ψ)
∆i
G¯n(Ti|Wi) (1)
is under mild conditions a consistent estimator for the full data risk EFX,0{L(X,ψ)}. Moreover,
in the absence of censoring, (1) reduces to the desired empirical risk. As such, it is reasonable
to estimate ψ(W ) by minimizing (1). One can also estimate G¯0(·|·) using covariates other
than those used for estimating ψ(W ), allowing for certain forms of informative censoring. An
important drawback of (1) is the need for G¯n(·|W ) to be consistently estimated.
2.3 The Brier Score
As suggested in Section 2.2.1, the prediction of survival status at a given time t may be viewed
as a loss minimization problem: estimate ψt(W ) by minimizing the average full data loss
function n−1
∑n
i=1 L(Xi, ψ), where L(Xi, ψ) = {Zi(t)−ψ(Wi)}2 and Zi(t) = I(Ti > t). In Graf
et al. (1999), this empirical loss function is referred to as the Brier score, and is proposed as
a measure of prediction inaccuracy that permits comparisons between competing models for
ψ0t(W ) = P (T > t|W ). Graf et al. (1999) also extend the definition of the Brier score to
accommodate censored survival data. In particular, given a time t, they propose to divide the
observations into three groups. Group 1 contains subjects censored before t; here, ∆i = 0,
T˜i ≤ t and Zi(t) cannot be determined. Group 2 contains subjects experiencing an event before
t; here, ∆i = 1, T˜i ≤ t, and Zi(t) = 0. Group 3 contains subjects that remain at risk for an event
at time t; here, the value of ∆i is irrelevant, for T˜i > t and thus Zi(t) = 1. The corresponding
average observed data loss function, generalized here to allow for covariate-dependent censoring
and assuming t 6= T˜i for any i, is computed as follows:
BSc(t) =
1
n
n∑
i=1
[
{0− ψˆt(Wi)}2 × I(T˜i ≤ t,∆i = 1)
G¯n(T˜i|Wi)
+ {1− ψˆt(Wi)}2 × I(T˜i > t)
G¯n(t|Wi)
]
(2)
where I(T˜i ≤ t,∆i = 1) is the indicator function for Group 2, I(Ti > t) is the indicator
function for Group 3, and G¯n(·|W ) estimates the censoring survival function G¯0(·|W ) = P (C ≥
·|W ). Observe that subjects in Group 1 do not contribute to this loss function except through
estimation of G¯0(·|W ).
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We now demonstrate that BSc(t) has an interesting IPCW representation. Proceeding
similarly to Strawderman (2000), define T˜i(t) = min(Ti(t), Ci) and ∆i(t) = I{Ti(t) ≤ Ci},
where Ti(t) = min(Ti, t). Clearly, ∆i(t) → ∆i as t → ∞ and it is evident that any subject
with ∆i = 1 must also have ∆i(t) = 1 for every t. Thus, the importance of ∆i(t) only becomes
apparent when ∆i = 0; in particular, for a given t <∞, it is possible for ∆i = 0 and ∆i(t) = 1.
Specifically, for a subject in Group 1, since ∆i = 0 and T˜i ≤ t, we have Ci ≤ t and Ci < Ti. It
follows that T˜i(t) = Ci and ∆i(t) = 0 (i.e., except if t = Ci, which is impossible if t 6= T˜i for any
i). For a subject in Group 2, since ∆i = 1 and T˜i ≤ t, we have Ti ≤ Ci and Ti ≤ t. It follows
that I(T˜i ≤ t,∆i = 1) = ∆i(t) = 1 and that T˜i(t) = Ti. For a subject in Group 3, we have T˜i > t
regardless of ∆i and therefore that Ti > t and Ci > t. It follows that I(T˜i > t) = ∆i(t) = 1 and
that T˜i(t) = t. It is then easy to show that (2) may be written as:
BSc(t) =
1
n
n∑
i=1
∆i(t)
G¯n{Ti(t)|Wi} ×
{
Zi(t)− ψˆt(Wi)
}2
. (3)
The IPCW-like risk estimator BSc(t) uses a modified event time and censoring indicator and
will be consistent for the expected (full data) Brier score under mild regularity conditions.
Such a loss function is also easily extended to the setting of multiple time points; for example,
estimators for ψ0(W ) might be obtained by minimizing loss functions of the form
∑p
r=1BS
c(tr),∫ τ
0 BS
c(t)w(t)dt, or even max{BSc(t1), BSc(t2), . . . , BSc(tp)}. In comparison with estimators
derived from the L2 loss function, loss functions derived from the Brier score have a nice
invariance property, being unaffected by monotone transformations of the time-to-event variable
(i.e., whether or not censoring is present).
2.4 partDSA: recursive partitioning for full data structures and extensions
partDSA (Molinaro et al., 2010) is a statistical methodology for predicting outcomes from
a complex covariate space with fully observed data. Similarly to CART, this novel algorithm
generates a piecewise constant estimation list of increasingly complex candidate predictors based
on an intensive and comprehensive search over the entire covariate space. A brief description
is below; see Molinaro et al. (2010) for further details.
The strategy for estimator construction, selection, and performance assessment in partDSA
is entirely driven by the specification of a loss function and involves three main steps. Step
1 involves defining the parameter of interest as the minimizer of an expected loss function
(i.e. risk), where the given loss function represents a desired measure of performance. In
Step 2, candidate estimators are constructed by minimizing the corresponding empirical risk
(i.e. average loss) function. For this reason, the regression function ψ(W ) should ideally
be parameterized in a way that generates a simple estimator. partDSA relies on piecewise
constant regression models to approximate the desired parameter space and uses three types
of operations to build these models (illustrated in Web Appendix A). Finally, in Step 3, cross-
validation is used to estimate risk and to select an optimal estimator among the candidate
estimators obtained in Step 2 (e.g., van der Laan and Dudoit, 2003). The partDSA software,
currently implemented for problems without missing data for select loss functions (e.g., L2) is
available on CRAN as an R package (Molinaro et al., 2009).
The results summarized in Section 2.2.2 demonstrate how the problem of estimating a pa-
rameter that minimizes the full data risk under a given loss function can be generalized to right-
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censored outcome data: replace the desired average full data loss with the corresponding average
observed data IPCW-weighted loss. Hence, the L2-loss-based estimation capabilities of partDSA
may be extended to right-censored outcomes in the following two ways: (i) partDSAIPCW , that
is, partDSA implemented using the average loss function (1) with L(Xi, ψ) = {Zi − ψ(Wi)}2.
and, (ii) partDSABrier, that is, partDSA implemented using the weighted L2 loss function
(3) for the binary outcome Zi(t). Notably, the first extension generalizes the Koul-Susarla-
van Ryzin estimator for the accelerated failure time model (Koul et al., 1981) allowing for
covariate-dependent censoring and a tree-based regression function.
3 Simulation Studies
We ran four simulation studies to evaluate the performance of partDSAIPCW and several vari-
ations on the Brier score loss function. In addition to these adaptations of partDSA, we include
for the sake of comparison the methods of LeBlanc and Crowley (1993, L&CNLL) and the
IPCW-based extension of CART developed in Molinaro et al. (2004, CARTIPCW ). The varia-
tions on the Brier score loss function include BSc(t) (1Fixed, with t set equal to a fixed time
point) and two aggregate loss functions, one based on five evenly spaced time points (5Even)
and the other using five percentiles derived from the Kaplan-Meier estimate of the marginal
survival distribution (5KM). Further details on these loss function specifications and algorithm
tuning parameters may be found in Web Appendix B.
The structure of each simulation study is the same. First, a training set of 250 observations
was generated with a nominal censoring level (0%, 30% or 50%); a model size (i.e., number of
terminal partitions) is then determined using the first minimum of the 5-fold cross-validated risk.
The performance of this model is then assessed with an independent test set of 5000 observations
generated from the full data distribution described in Section 3.1 (i.e. no censoring). This
process was repeated for 1000 independent (training, test) set combinations.
Each simulation study involves five covariates W1 . . .W5, each of which is a discrete uniform
variable on the integers 1-100. Only W1 and W2 influence survival times; these are generated
from an exponential distribution with a covariate-dependent mean parameter σ. We consider
both a “high” and ‘low” signal setting. In the high signal scenario, σ is set equal to 5 if
W1 > 50 or W2 > 75 and 0.5 otherwise; in the low signal scenario, the values for σ are 1 and
0.5 respectively.
Importantly, there is a single true regression model in each study having two correct regres-
sion tree representations. The true CART tree structure has three terminal nodes; however,
two of these nodes represent distinct subpopulations of subjects having the same survival dis-
tribution. In contrast, the true partDSA tree has two terminal partitions, combining these
two terminal nodes into a single partition (i.e., a more parsimonious representation). Figure 1
summarizes these representations for both the high and low signal settings.
In each study, censoring times are independently generated from uniform distributions. For
each signal level, two censoring settings are considered. In the first setting, censoring is allowed
to depend on covariate information, such that an (approximately) equal level of censoring
exists in both risk groups that is close to the specified nominal level. In the second setting,
censoring is generated independently of all covariate information, such that overall censoring
levels approximately match the specified nominal level. Censoring probabilities used in the
calculation of censoring weights are respectively estimated using survival curves derived from
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an incorrectly specified Cox regression model (i.e., the correct variables are included, but not
modeled correctly) and a properly specified nonparametric product-limit estimate of survival.
To ensure these estimated censoring probabilities remain bounded away from zero, observed
survival times are truncated using a sample-dependent truncation time, as described in Web
Appendix B. The actual censoring level decreases slightly after truncation; therefore, both
nominal and empirical levels are reported.
Below, we only report results for the setting of covariate-dependent censoring in Section
3.2, where censoring probabilities are estimated using Cox regression. Important performance
differences in the setting of covariate-independent censoring are highlighted; figures and tables
referenced but not found in the main document may be found in Web Appendix C. Notably,
since CARTIPCW and partDSAIPCW use the same loss function, a direct comparison of these
results illustrates the difference between the partDSA and CART algorithms, controlling for
both censoring type and level. However, before giving these results, we first describe the metrics
that will be used to evaluate prediction performance in the test set.
[Figure 1 about here.]
3.1 Test Set Evaluation Criteria
Performance evaluations are based on four criteria: prediction concordance, prediction error,
proper risk stratification, and pairwise predictive similarity. In each case, we intend to evaluate
how well a model built using censored data performs on an independent, fully observed test set
(i.e., no censoring). For brevity, we use “tree” and “terminal node” to describe the structure
and output for both partDSA and CART in this section, with the understanding that the true
meanings do differ somewhat for partDSA. Below, a brief description of each measure is given;
a detailed description of each measure may be found in Web Appendix C.
Prediction Concordance (Cp, C¯p): To ensure comparability across the different methods
of tree construction, we define prediction concordance using the terminal-node-specific IPCW-
estimated average survival time derived from the training set data as the predicted outcome.
Observed and predicted outcomes for subjects in the test set are then compared using the
concordance index Cp (Harrell et al., 1982) and a modification C¯p suggested in Yan and Greene
(2008) that typically exhibits less bias in settings where ties between predicted values are
possible. Values near 1.0 (0.5) indicate excellent (poor) concordance.
Prediction Error (Lp): In this method of evaluation, we compare for each method the
predictions for each test set subject obtained using the true tree structure (cf. Figure 1) and
the corresponding estimated tree structure. The average squared error of the difference in these
predictions, Lp, equals zero if and only if both trees classify all test set subjects into the same
risk groups, and increases away from zero as the heterogeneity in risk group assignment, hence
predicted risk, increases.
Pairwise Prediction Similarity (Dp): This criterion, motivated by work in Chipman et al.
(2001), targets the ability of each method to identify groups of subjects having a similar level of
risk. In particular, considering all possible pairings of subjects, this measure looks at the extent
to which each true tree and corresponding set of estimated trees classify pairs of subjects into
the same risk groups. With perfect agreement, Dp = 1; with perfect disagreement, Dp = 0. An
advantage of this metric is its independence from both tree topology and the actual predictions
associated with each terminal node.
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Risk Stratification: This criterion also focuses on the ability to properly separate patients
into groups of differing risk. In particular, for each of the 1000 independent test sets, node-
specific empirical survivor functions are computed. Then, for each estimation method, and for
the subset of the 1000 estimated trees that consist of either two or three terminal nodes, we
compute the corresponding empirical survivorship and 0.025 and 0.975 percentiles on a fine grid
of time points. A graphical summary of the results is provided for each simulation study. As
suggested by Figure 1, we expect to see a high proportion of cases for partDSA (CART) with
only two (three) survival curves and smaller (larger) standard errors.
3.2 Results
As seen in Table 1, all methods build slightly larger models than necessary while selecting the
two signal variables consistently. Overall, partDSABrier(5even) and partDSAIPCW exhibit the
best performance on the evaluation metrics introduced in Section 3.1, with partDSAIPCW also
consistently outperforming CARTIPCW .
In general, c-indices are comparable, with the partDSA methods doing as well, and usually
better, than the CART-based methods. The relative improvement in performance based on
the mean c-index ranges up to 6%, with the greatest improvement being seen at the highest
censoring level. In addition, partDSAIPCW and partDSABrier(5KM) have the lowest prediction
error in the presence of censoring, with partDSAIPCW having the lowest prediction error for
0% and 30% censoring and partDSABrier(5KM) having the lowest error in the case of 50%
censoring. In comparison with the CART-based methods, the relative decrease in prediction
error ranges up to 53%. In comparison with CART-based methods, the partDSA methods also
perform approximately 15% better on the pairwise prediction similarity measure. Web Figures
4-6 depict the average empirical survival curves for the four methods, where the partDSA and
CART methods routinely identify two and three distinct groups of patients, respectively; see
Web Table 1). However, in the case of CART, the clinical utility of these three risk groups is not
as apparent, for two of these groups are estimated to have nearly identical survival experiences,
each having wider standard errors.
In general, some variation in performance is observed across the different choices of Brier
score loss function, with partDSABrier(5KM) consistently performing well on all four metrics,
followed by partDSABrier(1Fixed) and then partDSABrier(5even). The difference in perfor-
mance between partDSABrier(5KM) and partDSABrier(5even) is noticeable and cannot be
explained by the introduction of censoring, for the performance of both is reasonably stable
for each metric across censoring levels. This is less true for partDSABrier(1Fixed), where more
substantial changes in prediction error and pairwise predictive similarity are observed with
increasing levels of censoring.
[Table 1 about here.]
There is greater heterogeneity in the performance comparison for the case of covariate-
independent censoring; see Web Table 3. Noteworthy observations include (i) a consistent
dominance of the CART-based method L&CNLL on the prediction error metric in the presence
of censoring; (ii) the consistent and generally high level of performance of partDSABrier(5KM)
on all metrics; and, (iii) the continued dominance of partDSAIPCW over CARTIPCW on all met-
rics regardless of censoring level, despite a more noticeable degradation in performance on the
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prediction error and pairwise predictive similarity indices as censoring increases in comparison
with Table 1.
The results of the low signal simulation are summarized in Table 2. All methods select
models less than the ideal size, choosing fewer correct W1-W2 variables, though still with
greater frequency in comparison with the incorrect W3-W5 variables. Further information on
chosen model sizes may be found in Web Table 2. In general, the partDSA methods perform
similarly to the CART methods on all four performance metrics; however, relative to CART,
moderate improvement is observed at the 50% censoring level on all metrics for partDSAIPCW
and partDSABrier(5Even). Empirical survival curves are summarized in Web Figures 7–9, where
patterns are generally similar to those reported earlier. Similar results are observed in the case
of covariate-independent censoring, though the improvement observed at the 50% censoring
level in the high signal setting is no longer evident; see Web Tables 5 and 6 and Web Figures
13 –15.
[Table 2 about here.]
4 Data Analysis
We now illustrate the model building capabilities of partDSA- and CART-based methods using
data from 12 North American Brain Tumor Consortium (NABTC) Phase II clinical trials for
recurrent glioma (Wu et al., 2010), run to assess the efficacy of novel therapeutic agents in
patients with grade III or IV gliomas. As there are few efficacious treatments for high-grade
glioma and median survival is low (14.6 months; Stupp et al., 2005), there is strong interest
in identifying prognostic factors associated with overall survival. Recently, several studies have
combined data from multiple (necessarily small) Phase II clinical trials to examine such factors
using a various statistical methods; however, findings have at best been moderately consistent
(Wong et al., 1999; Carson et al., 2007; Wu et al., 2010).
Wu et al. (2010) combined the NABTC data with 15 North Central Cancer Treatment
Group (NCCTG) trials and found tumor grade, patient age, baseline performance score, and
time since diagnosis as important prognostic variables. Based on these results and those of
earlier studies, Wu et al. (2010) conclude that there is strong evidence to suggest that future
trials should collect and report this information as predictors of patient prognosis. Limitations
of these analyses, and those to be presented below, include the possibility of trial referral bias
and biases induced as a result of variation in patient eligibility criteria across studies.
The NABTC data set analyzed here includes 549 patients that were treated on Phase II trials
between February 1998 and December 2002 (Wu et al., 2010); Web Table 7 summarizes the data
on 18 variables that include age, gender and several variables documenting a patient’s health
and tumor status as well as current/past therapies. The outcome of interest is overall survival
(OS), defined as time from study registration date to the date of death due to any cause (median
OS was 30.4 weeks). Thirty patients were censored at last follow-up date, being still alive or
lost to follow-up. There are several noteworthy differences between the analysis and results
here and in Wu et al. (2010). First, many of the results in that paper refer to the combined
analysis of 27 trials, not just the 12 trials considered here; in addition, and important to the
motivation for our analysis, is the fact that the risk groups ultimately identified in Wu et al.
(2010, Table 5) were determined by post-processing the results of their analyses in a subjective
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and relatively ad hoc manner. In particular, their primary analysis consisted of estimating the
cumulative hazard function for OS using a Cox proportional hazard model adjusted only for
current temozolomide (TMZ) use and then subsequently analyzing this predicted count using
CART without any further accounting for censoring. In subsequent analysis, logrank tests were
used to test for pairwise differences between terminal nodes; terminal nodes were then combined
for the purposes of defining risk groups if the p-value from a corresponding log-rank test was
> 0.01 (Wu et al., 2010, Table 5). That is, Wu et al. (2010) form risk groups using a combination
of ’and’ statements derived from CART and ’or’ statements created using the indicated testing
procedure. Important differences between their approach and partDSA include an improper
accounting for censoring, a lack of objectivity in the methodology used for defining risk groups,
and the failure to use cross-validation in evaluating the final models.
All four algorithms from Sect. 3 were run using 10-fold cross-validation; below, we summarize
the results from partDSABrier(5KM) and L&CNLL, with further discussion of the remaining
results in Web Appendix D. The risk stratification determined by partDSABrier(5KM) is based
on Karnofsky performance score (KPS; a marker for overall tumor burden and cumulative
treatment-related toxicity), patient age, time since diagnosis, baseline steroid use, gender, prior
TMZ therapy (an approved treatment for recurrent gliomas), and current TMZ therapy. Three
primary risk groups are identified; these are depicted in Table 3, with corresponding survival
experiences summarized by Kaplan-Meier curves in the left panel of Figure 6. The low, medium
and high risk groups respectively have median survival times of 55.6 weeks (144 patients), 32.3
weeks (218 patients), and 19.7 weeks (187 patients); see Table 3. In a sub-analysis of the
NABTC data, Wu et al. (2010, Table 7) found the same first five variables using a predicted
outcome variable that adjusts for current TMZ therapy. Hence, the only difference in the
variables selected is the inclusion of prior TMZ use; this clinically relevant variable indicates
that a patient previously failed TMZ therapy, lessening the chances of successful treatment.
For comparison, Table 4 and Figure 6 (right panel) summarize the corresponding results
for L&CNLL. It is observed that L&CNLL selects only two of the variables identified by
partDSABrier(5KM) (i.e. age split at 55 and prior TMZ), but creates three risk groups.
The lowest risk group is defined by younger patients without prior TMZ treatment (median
survival of 46.3 weeks, 176 patients); the highest risk group is defined by older patients (me-
dian survival of 25.3 weeks, 195 patients). The two groups at higher risk are also observed to
have very similar survival experiences, and the estimated spread in median survival times is
approximately 15 weeks shorter for L&CNLL. With the exception of the low risk group, the
reported 95% confidence intervals for median survival times associated with the Kaplan-Meier
curves for partDSABrier(5KM) are also considerably tighter than those associated with the
risk groups identified by L&CNLL. Arguably, the separation in risk identified here is not as
clinically relevant as that found by partDSA. We note here that the 95% confidence intervals
presented in these two tables are only meant to provide a sense of variability; because of the
post-hoc manner in which they are obtained, such intervals are not expected to have the correct
frequentist coverage. Further comments and comparisons to results in Wu et al. (2010) may be
found in Web Appendix D.
[Table 3 about here.]
[Figure 2 about here.]
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[Table 4 about here.]
In earlier analyses of other glioma studies, Wong et al. (1999) found histologic diagnosis
at study registration (i.e., grade), prior treatment(s), and KPS to be associated with overall
survival, whereas Carson et al. (2007) noted initial histology (GBM vs other; i.e., grade), age,
KPS, baseline steroid use, shorter time from original diagnosis to recurrence, and tumor outside
frontal lobe to be prognostic. As implied in earlier discussion, Wu et al. (2010) found grade
to be important in the recursive partitioning analysis of the NCCTG trials alone and also in
combination with the NABTC trials; however, grade was not identified as being prognostic
when looking only at the NABTC trials. In combination with our own analyses of the NABTC
trial data, we conclude that prior TMZ therapy, baseline steroid use, and gender should be
incorporated into the set of variables that Wu et al. (2010) recommend for consideration when
planning future clinical trials of high-grade glioma patients.
5 Discussion
The ability to successfully build a model for predicting a survival outcome has important clinical
implications. Censored survival outcomes have inherent challenges compared to continuous
and categorical outcomes; the development of tree-based methods for analyzing survival data
deserves further attention and study. We have introduced two methods for extending partDSA
to right-censored outcomes: the IPCW and Brier Score weighting schemes. In simulation
studies, these two methods are observed to perform as well, and often considerably better,
than either CARTIPCW or L&CNLL using several distinct evaluation criteria. As illustrated in
Figure 1, greater stability can be expected from the partDSA representation since fewer terminal
partitions are needed to represent distinct groups of subjects with similar levels of risk.
The partDSABrier methodology holds clear promise for risk stratification on the basis of
survival probabilities, particularly so the “integrated” (i.e., composite loss) versions. Compared
with the two other IPCW-L2−loss based methods, partDSABrier maintains good performance
for higher censoring levels. In part, we attribute this good behavior to both a sensible target
of estimation and the calculation of IPC weights at time points bounded away from the tail
of the survivor distribution. The partDSABrier methods also make better use of the available
failure time information by including both observations that are uncensored and censored after
a specified time cutpoint; whereas IPCW (for both algorithms) only directly includes uncen-
sored observations. This additional utilization of information may reduce the variability in
the estimated loss functions, resulting in improved performance; see Strawderman (2000) for
related discussion. Finally, the “integrated” (i.e., composite loss) version of the Brier score
loss function has two useful robustness properties: invariance to monotone transformations of
time; and, strong connections to estimating median, rather than mean, survival (Lawless and
Yuan, 2010, Theorem 1). As a result, the performance of partDSABrier as a risk stratification
procedure is less likely to be influenced by the presence of a few extreme response values.
Although partDSA has advantages over CART, one important fixed disadvantage is its
greater computational burden. In particular, because partDSA iterates among three possible
moves and performs an exhaustive search of the covariate space, it will inevitably require a
significantly higher running time than CART. The R package for partDSA allows for the cross-
validation folds to be run in parallel, making runnings time feasible in many applications (Moli-
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naro et al., 2010), especially given that most clinical datasets remain relatively modest in size.
In future work, we will look further at variable selection in partDSA and corresponding variable
importance measures. Such extensions will serve to further improve the already-demonstrated
potential of partDSA.
6 Supplementary Materials
Web Appendices, Tables, and Figures referenced in Sections 2 – 4 are available at the end of
this paper.
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Figure 1: True Models for Multivariate Simulations of Section 3.2. Panel (a): High Signal:
CART representation. Panel (b): High Signal: partDSA representation. Panel (c): Low Signal:
CART representation. Panel (d): Low Signal: partDSA representation.
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Figure 2: Kaplan-Meier Curves for NABTC data analysis in Section 4.
Left panel: partDSABrier(5KM) stratification of patients into three risk groups. Right panel:
L&CNLL stratification of patients into three risk groups.
Table 1: Simulation Results: High Signal, Covariate-Dependent Censoring. Reported are true
and average fitted model sizes, number of predictors in the fitted model, number of correct (in-
correct) predictors selected, c-index ratios (Cp, C¯p; larger values indicate better performance),
prediction error (Lp; smaller values indicate less error), and pairwise prediction similarity er-
ror (Dp; larger values indicate less error) for the four methods over three censoring levels for
the simulation. The 1Fixed method refers to partDSABrier using a single fixed time point; the
5even method refers to partDSABrier using 5 evenly spaced time points; and, the 5KM method
refers to partDSABrier using 5 time points determined using percentiles of the Kaplan-Meier
estimate of the marginal survivor function.
partDSABrier IPCW
Censoring Criteria 1Fixed 5Even 5KM partDSA CART L&CNLL
True Model Size 2.00 2.00 2.00 2.00 3.00 3.00
0%/0%
Fitted Size 2.198 2.450 2.228 2.170 3.106 3.192
# Predictors 2.135 2.095 2.195 2.111 2.047 2.076
# W1-W2 1.998 1.809 2.000 1.999 1.962 1.996
# W3-W5 0.137 0.286 0.195 0.112 0.085 0.080
Cp 0.879 0.828 0.880 0.891 0.812 0.809
C¯p 0.782 0.748 0.783 0.789 0.748 0.747
Lp 0.082 0.270 0.076 0.061 0.076 0.072
Dp 0.944 0.838 0.946 0.964 0.845 0.842
30%/26.4%
True Size 2.000 2.000 2.000 2.000 3.000 3.000
Fitted Size 2.249 2.391 2.227 2.230 3.058 3.222
# Predictors 2.190 2.160 2.206 2.146 1.988 2.090
# W1-W2 1.993 1.894 2.000 1.999 1.904 1.988
# W3-W5 0.197 0.266 0.206 0.147 0.084 0.102
Cp 0.867 0.839 0.878 0.881 0.810 0.802
C¯p 0.775 0.756 0.783 0.784 0.744 0.742
Lp 0.125 0.225 0.084 0.082 0.126 0.118
Dp 0.918 0.857 0.940 0.944 0.828 0.825
50%/45.7%
True Size 2.000 2.000 2.000 2.000 3.000 3.000
Fitted Size 2.396 2.361 2.251 2.359 2.937 3.093
# Predictors 2.137 2.136 2.200 2.191 1.875 1.983
# W1-W2 1.908 1.888 1.997 1.974 1.802 1.881
# W3-W5 0.229 0.248 0.203 0.217 0.073 0.102
Cp 0.845 0.844 0.874 0.864 0.810 0.794
C¯p 0.761 0.759 0.781 0.775 0.740 0.732
Lp 0.199 0.216 0.102 0.125 0.188 0.215
Dp 0.862 0.855 0.926 0.906 0.805 0.792
Table 2: Simulation Results: Low Signal, Covariate-Dependent Censoring. Reported are true
and average fitted model sizes, number of predictors in the fitted model, number of correct
predictors selected, c-index ratios (Cp, C¯p; larger values indicate better performance), prediction
error (Lp; smaller values indicate less error), and pairwise prediction similarity error (Dp; larger
values indicate less error) for the four methods over three censoring levels for the simulation.
The 1Fixed method refers to partDSABrier using a single fixed time point; the 5even method
refers to partDSABrier using 5 evenly spaced time points; and, the 5KM method refers to
partDSABrier using 5 time points determined using percentiles of the Kaplan-Meier estimate of
the marginal survivor function.
partDSABrier IPCW
Censoring Criteria 1Fixed 5Even 5KM partDSA CART L&CNLL
True Model Size 2.00 2.00 2.00 2.00 3.00 3.00
0%/0%
Fitted Size 1.642 1.502 1.389 1.456 1.590 1.873
# Predictors 0.705 0.521 0.496 0.586 0.571 0.838
# W1-W2 0.621 0.471 0.410 0.491 0.527 0.786
# W3-W5 0.084 0.050 0.086 0.095 0.044 0.052
Cp 0.608 0.604 0.602 0.607 0.603 0.610
C¯p 0.567 0.562 0.559 0.563 0.563 0.571
Lp 0.080 0.086 0.091 0.087 0.083 0.071
Dp 0.618 0.592 0.581 0.600 0.608 0.644
30%/26.7%
Fitted Size 1.550 1.536 1.290 1.456 1.571 1.546
# Predictors 0.676 0.648 0.427 0.705 0.553 0.523
# W1-W2 0.575 0.527 0.319 0.551 0.517 0.473
# W3-W5 0.101 0.121 0.108 0.154 0.036 0.050
Cp 0.607 0.604 0.597 0.611 0.607 0.607
C¯p 0.565 0.562 0.554 0.565 0.565 0.563
Lp 0.073 0.076 0.084 0.076 0.073 0.075
Dp 0.607 0.591 0.565 0.605 0.609 0.597
50%/45.7%
Fitted Size 1.648 1.780 1.306 1.591 1.572 1.282
# Predictors 0.812 1.106 0.533 0.943 0.552 0.264
# W1-W2 0.659 0.911 0.375 0.758 0.513 0.233
# W3-W5 0.153 0.195 0.158 0.185 0.039 0.031
Cp 0.607 0.616 0.602 0.614 0.607 0.601
C¯p 0.566 0.574 0.556 0.570 0.565 0.555
Lp 0.056 0.049 0.066 0.055 0.058 0.067
Dp 0.609 0.649 0.571 0.629 0.608 0.562
Table 3: partDSABrier(5KM) stratification of NABTC patients (Sect. 4) into three risk groups
(column 1: low, intermediate (Int), and high). Corresponding median survival in weeks and
95% confidence intervals (CI) are given in column 2 and number of patients in each group in
column 3. Variables included in the model (columns 4–10) are Karnofsky performance score
(KPS), age, current TMZ, time since diagnosis (Dx), prior TMZ, baseline steroid use (steroid),
and gender.
Variables
Risk Median survival n Current Time Since Prior
Group (95% CI) (549) KPS Age TMZ Dx TMZ Steroid Gender
Low 144
≥ 90 ≤ 55 No
55.6 ≤ 80 No No Female
(48.6, 66.3) ≤ 80 Yes ≤ 16.9
≤ 80 Yes (24, 33.7]
Int. 218
≥ 90 Yes
32.3 ≥ 90 > 55 No
(28.1, 36.9) ≤ 80 Yes < 33.7
High 187
≤ 80 No Yes
19.7 ≤ 80 No No Male
(18.3, 21.9) ≤ 80 Yes (16.9, 24]
Table 4: L&CNLL stratification of NABTC patients (Sect. 4) into three risk groups (column 1:
low, intermediate (Int), and high). Corresponding median survival in weeks and 95% confidence
intervals (CI) are given in column 2 and number of patients in each group in column 3. Variables
included in the model (columns 4–5) are age and prior TMZ.
Risk Median survival n Variables
Group (95% CI) (549) Age Prior TMZ
Low 46.3 (40.9, 54.7) 176 ≤ 55 No
Intermediate 27.3 (22.3, 33.3) 177 ≤ 55 Yes
High 25.3 (21.7, 28.3) 196 > 55
Web-based Supplemental Materials for
A Partitioning Deletion/Substitution/Addition Algorithm for
Creating Survival Risk Groups
by Karen Lostritto, Robert L. Strawderman, and Annette M. Molinaro
Web Appendix A: Further detail on partDSA
partDSA utilizes three moves, or step functions, to generate index sets (i.e., different partition-
ings of the covariate space) with the goal of minimizing a risk function over all the generated
index sets. These three moves include:
• Deletion: A deletion move forms a union of two regions of the covariate space regardless
of their spatial location, i.e., the two regions may not be contiguous. An example is shown
in Figure 1.
• Substitution: A substitution move divides two disparate regions into two subsets each
and then forms combinations of the four subsets resulting in two new regions. Thus, this
step forms unions of regions (or subsets within the regions) as well as divides regions.
The possible subsets of two regions and combinations thereof can be seen in Figure 2.
• Addition: An addition move splits one region into two distinct regions. An example is
shown in Figure 3.
1
Figure 1: Two dimensional display of Deletion Step. Two disparate regions on the left form a
union on the right. This union reads: ”If low on Z1 and high on Z2 OR low on Z2 and high
on Z1.”
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Figure 2: Possible Substitution Moves for two disparate regions. The ’best’ split on Region 1
(R1) is found and labeled a and b. The ’best’ split on Region 2 (R2) is found and labeled c
and d. All (six) unique combinations of a, b, c, and d are formed as Rs1 and Rs2.
3
Figure 3: Two dimensional display of Addition Step. The algorithm is initiated on the left and
the ’best’ split is found separating ’low’ on Z1 from ’high’.
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Web Appendix B: Computational Details For Simulation Studies
The rpart package version 3.1-49 available in R was used for the L&CNLL method, and code
from Molinaro et al. (2004), also based on rpart, for CARTIPCW . The default tuning pa-
rameters were used for rpart except as noted below. In partDSA, version 0.8.2 (available on
R-forge), MB, defined as the minimum number of observations per “or” statement was set to
15. In rpart, minbuck, the minimum number of observations per node was set to 15. To allow
both algorithms the opportunity to build the same size models we set rpart’s minsplit to 30.
The minimum percent difference (MPD) in partDSA is a threshold for the required improve-
ment in the risk to make a particular move (e.g., deletion) and was set to 0.05. Additionally,
both algorithms were restricted to a max of 10 nodes or partitions. Five-fold cross validation
was carried out in a standardized way for all methods such that the partition of the observations
into the five folds was identical for each method.
As indicated in the main document, the observed survival times are truncated to help
ensure estimated censoring probabilities remain bounded away from zero. Specifically, we set
the sample-dependent truncation time τ such that the proportion of observed follow-up times
exceeding τ is 5% of the total sample size. All follow-up times exceeding τ are set equal to τ
and are subsequently considered uncensored. Consequently, all truncated survival times lie in
(0, τ ].
In the case of partDSABrier, a vector of times for loss computation must be chosen. As
described in the main paper, we simply used the theoretical median of the marginal survivor
function computed under the specified model in the case of partDSABrier(1Fixed). In the case
of partDSABrier(5Even) and partDSABrier(5KM), a sample-dependent vector of 5 time points
is used. For partDSABrier(5Even), we select the time points (j/6)τ for j = 1, 2, 3, 4, 5; for
partDSABrier(5KM), we compute the Kaplan-Meier estimate of the marginal survivor function
and then use the times that respectively correspond to survival probabilities of 0.85, 0.7, 0.55,
0.40 and 0.25. The loss BSc(t) in (2) is then computed for each of the 5 time points in both cases
and aggregated to obtain a composite measure of loss. In particular, if t1 < t2 < t3 < t4 < t5
denote these 5 time points, we compute the weighted average loss:
B∗ =
5∑
i=1
| ti
t5
|BSc(ti),
the weight |ti/t5| serving to emphasize later survival differences over earlier differences (and the
absolute value allowing for the possibility of times on the log scale); see Graf et al. (1999) for
further discussion.
Web Appendix C: Extended Detail for Multivariate Simulation
Studies
C.1: Detailed Description of Evaluation Measures
Prediction Concordance: To ensure comparability across the different methods of tree con-
struction, we define prediction concordance using the terminal-node-specific IPCW-estimated
5
average survival time derived from the training set data as the predicted outcome. For each
test set, all members are classified into a terminal node for each estimated tree based only on
their covariates and assigned a corresponding estimated average survival time as their predicted
outcome. The concordance index, or c-index, compares observed and predicted outcomes for
each method in each test set by computing the fraction of pairs in which the observation having
the shorter event time also has the shorter model-predicted event time (Harrell et al., 1982).
Since it is possible (indeed, expected) that test subjects with different outcomes will have tied
predicted values, we report two c-indices, one that excludes all such tied pairs (Cp) and another
that is calculated as the numerical average of this c-index and that calculated including all
such tied pairs (C¯p). The latter typically exhibits less bias in comparison to measures that
respectively exclude and include ties (Yan and Greene, 2008).
Prediction Error: In this method of evaluation, two predicted outcomes are computed for
each test set member for each estimation method. First, a predicted outcome is determined
by running all test set subjects down the true partDSA tree and then again down the corre-
sponding CART tree (cf. Figure 1). The predicted outcome for subject i, say ψTTi , is taken to
be the average survival time of all members assigned to the same terminal node. The second
predicted outcome is determined in exactly the same fashion, but instead runs each test set
member down the estimated tree built using the training set; call this predicted outcome ψTSi .
Comparing predictions over all subjects measures how well the estimated tree (i.e., structurally
speaking) predicts the true subject-specific risk. We measure the distance between these pre-
dicted outcomes using Lp = 1/5000
∑5000
i=1 (ψ
TT
i − ψTSi )2. Evidently, Lp = 0 if and only if both
trees classify all test set subjects into the same risk groups, and increases away from zero as
the heterogeneity in risk group assignment, hence predicted risk, increases.
Risk Stratification: This criterion focuses on the ability of each method to properly separate
patients into groups of differing risk. In particular, for each of the 1000 independent test sets,
node-specific empirical survivor functions are computed. Then, for each estimation method,
and for the subset of the 1000 estimated trees that consist of either two or three terminal nodes,
we computed the corresponding average survivorship and 0.025 and 0.975 percentiles on a fine
grid of time points. A graphical summary of the results is provided for each simulation study.
For partDSA, we expect to see a high proportion of cases with only two risk groups (i.e., survival
curves) and small standard errors. For CART, we expect to observe a high proportion of cases
with three risk groups, with two of these groups representing subpopulations having identical
survival distributions and corresponding estimates that consequently reflect greater levels of
error.
Pairwise Prediction Similarity: This last criterion also examines the separation of patients
into risk groups, targeting the ability of each method to identify groups of subjects having a
similar level of risk. Given the underlying tree model, the terminal node (hence risk group)
for each observation is known. Define IT (i, j) to be 1 if observations i and j are grouped
into the same terminal node (i.e., into the same risk group) under this true model and set it
equal to 0 otherwise. Then, IT (i, j) is known for each of the
(
n
2
)
unique pairs in each test
set. For structures estimated by partDSA and CART, we can compute analogous measures of
agreement/discrepancy for all unique test set pairs; generically, let this measure be denoted
by IM (i, j). Then, |IT (i, j) − IM (i, j)| > 0 if and only if an estimated tree incorrectly groups
6
observations i and j. Similarly to Chipman et al. (2001), define the distance measure
Dp = 1−
n∑
i=1
∑
j>i
|IT (i, j)− IM (i, j)|(
n
2
) (4)
With perfect agreement, Dp = 1; with perfect disagreement, Dp = 0. We report the average
value of Dp computed over all 1000 test sets. An advantage of this metric is its independence
from both tree topology and the actual predictions associated with each terminal node.
C.2: High Signal, Covariate-Dependent Censoring
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Multivariate Simulation 1 − High Signal: 0 Censoring
Figure 4: High Signal, Covariate-Dependent Censoring: Kaplan-Meier plots for six methods to
illustrate the survival experience of chosen risk groups (Section 3.2, 0% censoring).
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Multivariate Simulation 1 − High Signal: 30 Censoring
Figure 5: High Signal, Covariate-Dependent Censoring: Kaplan-Meier plots for six methods to
illustrate the survival experience of chosen risk groups (Section 3.2, 30% censoring).
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Multivariate Simulation 1 − High Signal: 50 Censoring
Figure 6: High Signal, Covariate-Dependent Censoring: Kaplan-Meier plots for six methods to
illustrate the survival experience of chosen risk groups (Section 3.2, 50% censoring).
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Table 1: High Signal, Covariate-Dependent Setting: proportion of the 1000 models at each
given size for each method at the three censoring levels.
Root Node 2 3 4+
0Cens
L&CNLL 0.001 0.001 0.869 0.129
CARTIPCW 0.018 0.001 0.861 0.120
partDSAIPCW 0.862 0.117 0.021
partDSABrier1fixed 0.821 0.140 0.039
partDSABrier5even 0.017 0.625 0.281 0.077
partDSABrier5KM 0.830 0.148 0.022
30Cens
L&CNLL 0.004 0.003 0.829 0.164
CARTIPCW 0.047 0.002 0.823 0.128
partDSAIPCW 0.814 0.151 0.035
partDSABrier1fixed 0.834 0.127 0.039
partDSABrier5even 0.014 0.707 0.195 0.084
partDSABrier5KM 0.817 0.143 0.040
50Cens
L&CNLL 0.043 0.029 0.783 0.145
CARTIPCW 0.094 0.010 0.785 0.111
partDSAIPCW 0.001 0.728 0.205 0.066
partDSABrier1fixed 0.001 0.813 0.146 0.040
partDSABrier5even 0.035 0.694 0.183 0.088
partDSABrier5KM 0.021 0.702 0.186 0.091
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C.3: Low Signal, Covariate-Dependent Censoring
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Multivariate Simulation 1  − Low Signal: 0 Censoring
Figure 7: Low Signal, Covariate-Dependent Censoring: Kaplan-Meier plots for six methods to
illustrate the survival experience of chosen risk groups (Section 3.2, 0% censoring).
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Figure 8: Low Signal, Covariate-Dependent Censoring: Kaplan-Meier plots for six methods to
illustrate the survival experience of chosen risk groups (Section 3.2, 30% censoring).
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Figure 9: Low Signal, Covariate-Dependent Censoring: Kaplan-Meier plots for six methods to
illustrate the survival experience of chosen risk groups (Section 3.2, 50% censoring).
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Table 2: Low Signal, Covariate-Dependent Setting: Proportion of the 1000 models at each
given size for each method at the three censoring levels.
Root Node 2 3 4+
0Cens
L&CNLL 0.458 0.287 0.207 0.048
CARTIPCW 0.559 0.320 0.096 0.025
partDSAIPCW 0.635 0.290 0.062 0.013
partDSABrier1fixed 0.693 0.239 0.055 0.013
partDSABrier5even 0.584 0.343 0.062 0.011
partDSABrier5KM 0.522 0.336 0.121 0.021
30Cens
L&CNLL 0.662 0.181 0.120 0.037
CARTIPCW 0.587 0.281 0.112 0.020
partDSAIPCW 0.645 0.272 0.068 0.015
partDSABrier1fixed 0.778 0.171 0.038 0.013
partDSABrier5even 0.621 0.271 0.077 0.031
partDSABrier5KM 0.580 0.313 0.089 0.018
50Cens
L&CNLL 0.815 0.115 0.055 0.015
CARTIPCW 0.597 0.263 0.114 0.026
partDSAIPCW 0.549 0.351 0.072 0.028
partDSABrier1fixed 0.780 0.159 0.043 0.018
partDSABrier5even 0.453 0.386 0.112 0.049
partDSABrier5KM 0.557 0.309 0.089 0.045
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C.4: High Signal, Covariate-Independent Censoring
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Multivariate Simulation 1 − High Signal: 0 Censoring
Figure 10: High Signal, Covariate-Independent Censoring: Kaplan-Meier plots for six methods
to illustrate the survival experience of chosen risk groups (Section 3.2, 0% censoring).
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Figure 11: High Signal, Covariate-Independent Censoring: Kaplan-Meier plots for six methods
to illustrate the survival experience of chosen risk groups (Section 3.2, 30% censoring).
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Figure 12: High Signal, Covariate-Independent Censoring: Kaplan-Meier plots for six methods
to illustrate the survival experience of chosen risk groups (Section 3.2, 50% censoring).
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Table 3: High Signal, Covariate-Independent Censoring: see caption of Table 1 for details.
partDSABrier IPCW
Censoring Criteria 1Fixed 5Even 5KM partDSA CART L&CNLL
True Model Size 2.00 2.00 2.00 2.00 3.00 3.00
0%/0%
Fitted Size 2.198 2.450 2.228 2.170 3.106 3.192
# Predictors 2.135 2.095 2.195 2.111 2.047 2.076
# W1-W2 1.998 1.809 2.000 1.999 1.962 1.996
# W3-W5 0.137 0.286 0.195 0.112 0.085 0.080
Cp 0.879 0.828 0.88 0.891 0.812 0.809
C¯p 0.782 0.748 0.783 0.789 0.748 0.747
Lp 0.082 0.27 0.076 0.061 0.076 0.072
Dp 0.944 0.838 0.946 0.964 0.845 0.842
30%/26.1%
Fitted Size 2.332 2.416 2.213 2.344 3.003 3.135
# Predictors 2.208 2.257 2.142 2.213 1.922 2.054
# W1-W2 1.986 1.958 1.999 1.985 1.839 1.999
# W3-W5 0.222 0.299 0.143 0.228 0.083 0.055
Cp 0.866 0.853 0.884 0.869 0.811 0.816
C¯p 0.777 0.768 0.787 0.778 0.743 0.754
Lp 0.105 0.152 0.078 0.105 0.162 0.058
Dp 0.913 0.884 0.948 0.921 0.813 0.848
50%/44.9%
Fitted Size 2.576 2.480 2.292 2.366 2.672 3.091
# Predictors 2.225 2.266 2.195 2.034 1.619 2.038
# W1-W2 1.875 1.982 1.990 1.753 1.551 1.997
# W3-W5 0.350 0.284 0.205 0.281 0.068 0.041
Cp 0.842 0.858 0.879 0.844 0.82 0.833
C¯p 0.766 0.78 0.791 0.763 0.746 0.772
Lp 0.159 0.096 0.082 0.212 0.235 0.043
Dp 0.837 0.884 0.928 0.84 0.773 0.85
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Table 4: High Signal, Covariate-Independent Setting: Proportion of the 1000 models at each
given size for each method at the three censoring levels.
Root Node 2 3 4+
0Cens
L&CNLL 0.001 0.001 0.869 0.129
CARTIPCW 0.018 0.001 0.861 0.120
partDSAIPCW 0.862 0.117 0.021
partDSABrier1fixed 0.821 0.140 0.039
partDSABrier5even 0.017 0.625 0.281 0.077
partDSABrier5KM 0.830 0.148 0.022
30Cens
L&CNLL 0.915 0.085
CARTIPCW 0.070 0.021 0.774 0.135
partDSAIPCW 0.748 0.188 0.064
partDSABrier1fixed 0.827 0.134 0.039
partDSABrier5even 0.008 0.720 0.178 0.094
partDSABrier5KM 0.004 0.754 0.178 0.064
50Cens
L&CNLL 0.001 0.001 0.930 0.068
CARTIPCW 0.107 0.227 0.567 0.099
partDSAIPCW 0.026 0.691 0.210 0.073
partDSABrier1fixed 0.002 0.781 0.160 0.057
partDSABrier5even 0.645 0.267 0.088
partDSABrier5KM 0.022 0.595 0.243 0.140
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C.5: Low Signal, Covariate-Independent Censoring
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Multivariate Simulation 1  − Low Signal: 0 Censoring
Figure 13: Low Signal, Covariate-Independent Censoring: Kaplan-Meier plots for six methods
to illustrate the survival experience of chosen risk groups (Section 3.2, 0% censoring).
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Multivariate Simulation 1 − Low Signal: 30 Censoring
Figure 14: Low Signal, Covariate-Independent Censoring: Kaplan-Meier plots for six methods
to illustrate the survival experience of chosen risk groups (Section 3.2, 30% censoring).
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Multivariate Simulation 1 − Low Signal: 50 Censoring
Figure 15: Low Signal, Covariate-Independent Censoring: Kaplan-Meier plots for six methods
to illustrate the survival experience of chosen risk groups (Section 3.2, 50% censoring).
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Table 5: Low Signal, Covariate-Independent Censoring: see caption of Table 2 for details.
partDSABrier IPCW
Censoring Criteria 1Fixed 5Even 5KM partDSA CART L&CNLL
True Model Size 2.00 2.00 2.00 2.00 3.00 3.00
0%/0%
Fitted Size 1.642 1.502 1.389 1.456 1.590 1.873
# Predictors 0.705 0.521 0.496 0.586 0.571 0.838
# W1-W2 0.621 0.471 0.410 0.491 0.527 0.786
# W3-W5 0.084 0.050 0.086 0.095 0.044 0.052
Cp 0.608 0.604 0.602 0.607 0.603 0.61
C¯p 0.567 0.562 0.559 0.563 0.563 0.571
Lp 0.08 0.086 0.091 0.087 0.083 0.071
Dp 0.618 0.592 0.581 0.6 0.608 0.644
30%/26.3%
Fitted Size 1.436 1.358 1.285 1.229 1.342 1.573
# Predictors 0.537 0.448 0.400 0.378 0.332 0.550
# W1-W2 0.441 0.354 0.315 0.272 0.285 0.516
# W3-W5 0.096 0.094 0.085 0.106 0.047 0.034
Cp 0.603 0.599 0.601 0.594 0.593 0.608
C¯p 0.56 0.556 0.556 0.551 0.552 0.565
Lp 0.076 0.08 0.081 0.084 0.081 0.071
Dp 0.586 0.57 0.571 0.559 0.569 0.606
50%/46.1%
Fitted Size 1.226 1.256 1.167 1.129 1.170 1.385
# Predictors 0.291 0.366 0.269 0.186 0.165 0.366
# W1-W2 0.210 0.274 0.171 0.123 0.122 0.334
# W3-W5 0.081 0.092 0.098 0.063 0.043 0.032
Cp 0.586 0.592 0.59 0.573 0.573 0.605
C¯p 0.547 0.551 0.548 0.538 0.539 0.56
Lp 0.059 0.058 0.06 0.061 0.061 0.055
Dp 0.549 0.56 0.548 0.542 0.545 0.579
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Table 6: Low Signal, Covariate-Independent Setting: Proportion of the 1000 models at each
given size for each method at the three censoring levels.
Root Node 2 3 4+
0Cens
L&CNLL 0.458 0.287 0.207 0.048
CARTIPCW 0.559 0.320 0.096 0.025
partDSAIPCW 0.635 0.290 0.062 0.013
partDSABrier1fixed 0.693 0.239 0.055 0.013
partDSABrier5even 0.584 0.343 0.062 0.011
partDSABrier5KM 0.522 0.336 0.121 0.021
30Cens
L&CNLL 0.620 0.228 0.120 0.032
CARTIPCW 0.727 0.215 0.048 0.010
partDSAIPCW 0.809 0.160 0.025 0.006
partDSABrier1fixed 0.765 0.191 0.040 0.004
partDSABrier5even 0.723 0.218 0.042 0.017
partDSABrier5KM 0.664 0.257 0.062 0.017
50Cens
L&CNLL 0.729 0.184 0.071 0.016
CARTIPCW 0.854 0.127 0.015 0.004
partDSAIPCW 0.892 0.092 0.012 0.004
partDSABrier1fixed 0.873 0.100 0.018 0.009
partDSABrier5even 0.787 0.175 0.033 0.005
partDSABrier5KM 0.827 0.138 0.027 0.008
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Web Appendix D: Descriptive Table for Glioma Dataset
The prognostic model building ability of the partDSA and CART methods are assessed with the
use of twelve North American Brain Tumor Consortium (NABTC) consecutive Phase II clinical
trials for recurrent glioma, detailed in Wu et al. (2010). As indicated in the main document, the
purpose of such trials is to assess the efficacy of novel therapeutic agents in patients with high-
grade gliomas (World Health Organization (WHO) grade III or IV), as glioblastoma patients
treated with standard of care have a dismal median survival of 14.6 months (Stupp et al., 2005).
Below, we expand the analysis of the NABTC trial considered in the main paper, and evaluate
the results of other methods used to define risk groups.
The partDSAIPCW method results in three risk groups (defined in Table 8) and is remark-
able as it separates a low risk group with median survival of 65 weeks, the highest of all low risk
groups (Fig. 16, left panel). These 59 patients are ≤ 55, have very high KPS (i.e. ≥ 90), no
prior TMZ, and if grade IV were also within 41 weeks of diagnosis. The intermediate risk group
has 335 patients and is defined by prior TMZ, Age, KPS, Grade, time since diagnosis, gender,
and baseline anticonvulsant therapy. The high risk group has 155 patients with median survival
of 19.4 weeks and is defined by prior TMZ, low KPS (≤ 80), and gender. In comparison to the
results presented in the main paper, this analysis does not identify current TMZ or steroids
as important predictors. The CARTIPCW tree in Table 9 only identifies two variables, prior
TMZ and KPS. The 108 patients in the low risk group have a median survival of 52.2 and are
defined by a high KPS and no prior TMZ. Interestingly, and similar to the L&CNLL results
shown in the right panel of Fig. 2, the CARTIPCW defined intermediate and high risk groups
have a similar survival experience (right panel of Fig. 16).
The partDSABrier(5Even) tree only separates out two risk groups (Table 10). The three
notable variables in this model are extent of resection (biopsy (Bx) vs. sub-total (ST) vs. gross
total (GT)), last known histology (Anaplastic astrocytoma (AA) vs. other), and grade. The 163
patients in the low risk group have median survival of 48.6 weeks, are younger, have ≤ 125 weeks
since diagnosis, and have typically not had prior TMZ. The survival curves for both groups are
shown in Fig. 17. A difference between this analysis and that based on partDSABrier(5KM)
relates to the time points used to determine risk groups; in the former, the times tend to
be smaller, and hence the factors identified here may at least partially reflect shorter-term
determinants of survival.
There are several notable differences between the analyses presented here and that in Wu
et al. (2010). First, we are limited to the 12 NABTC trials whereas Wu et al. (2010) combined
data from 27 NABTC and NCCTG trials. Second, some NABTC trials included both Phase I
and Phase II components. For the purposes of this analysis, if a patient was included in both
we only kept the clinical record for the Phase II component so that we had unique observations.
This reduced our sample size from 596 (as reported in Wu et al. (2010)) to 549. Third, the
NABTC trials used KPS instead of ECOG scale (as was used in the NCCTG trials); the results
for performance score in Wu et al. (2010) reflect both scores, whereas our analyses are limited
to KPS only. Fourth, in Wu et al. (2010), current TMZ is used to define an “adjusted survival
prediction” that is subsequently treated in the recursive partitioning analysis as an uncensored
response variable; in our analyses, current TMZ is included as an explanatory variable.
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Table 7: Baseline demographics for 12 NABTC trials.
Variable NABTC (n = 549; No. [%])
Age
Age (years) Median (range) 49 (20-85)
Gender
Female 196 (36)
Male 353 (64)
Race/ethnicity
Nonwhite 37 (7)
White 512 (93)
Karnofsky performance score
60 30 (5)
70 100 (18)
80 181 (33)
90 168 (31)
100 66 (12)
Missing 4 (1)
Year of study entry
1990-1999 174 (32)
2000-2004 375 (68)
Time since initial diagnosis
Time since initial diagnosis (weeks) Mean (range) 97 (10-814)
Last known grade
III 147 (27)
IV 402 (73)
Last known histology
Anaplastic astrocytoma 91 (17)
Anaplastic oligodendroglioma 37 (7)
Anaplastic oligoastrocytoma 19 (3)
Glioblastoma multiforme 402 (73)
Extent of primary resection
Biopsy 114 (21)
Subtotal resection 226 (41)
Gross total resection 145 (26)
Missing 64 (12)
Baseline steroid use
No 244 (44)
Yes 305 (56)
Baseline anticonvulsant use
No 123 (22)
Yes 426 (78)
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Table 7: (continued)
Variable NABTC (n = 549; No. [%])
Prior chemotherapy
Missing 1 (0)
No 117 (21)
Yes 431 (79)
Prior nitrosoureas
No 341 (62)
Yes 208 (38)
Prior TMZ use
No 277 (50)
Yes 272 (50)
Type of treatment center
Academic 549 (100)
Number of prior relapses
Missing 60 (11)
<=1 54 (10)
>=2 435 (79)
Initial low-grade histology
No 436 (79)
Yes 53 (10)
Missing 60 (11)
Current TMZ
No 367 (67)
Yes 182 (33)
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Figure 16: Kaplan-Meier Curves for NABTC data analysis in Section 4.
Left panel: partDSAIPCW stratification of patients into three risk groups. Right panel:
CARTIPCW stratification of patients into three risk groups.
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Figure 17: Kaplan-Meier Curves for partDSABrier(5even) analysis of NABTC data in Section
4
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Table 8: partDSAIPCW stratification of NABTC patients (Sect. 4) into three risk groups
(column 1: low, intermediate (Int), and high). Corresponding median survival in weeks and
95% confidence intervals (CI) are given in column 2 and number of patients in each group in
column 3. Variables included in the model (columns 4–10) are prior TMZ, age, Karnofsky
performance score (KPS), histological grade (Grade), time since diagnosis (Dx), gender, and
baseline anticonvulsant use.
Variables
Risk Median survival n Prior Time Since Baseline
Group (95% CI) (549) TMZ Age KPS Grade Dx Gender Anticon
Low 65 59 No ≤ 55 ≥ 90 III
(54.7, 92.6) No ≤ 55 ≥ 90 IV ≤ 40.9
Int 335
Yes ≥ 90
No ≤ 80 Female No
32.7 No > 55 ≥ 90
(28.7, 35.9) No ≤ 55 ≥ 90 IV > 40.9
Yes ≤ 80 ≤ 38.3 Female
No ≤ 80 Yes
High 155
Yes ≤ 80 Male
19.4 Yes ≤ 80 ≥ 38.3 Female
(18, 22.7) No ≤ 80 Male No
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Table 9: CARTIPCW stratification of NABTC patients (Sect. 4) into three risk groups (col-
umn 1: low, intermediate (Int), and high). Corresponding median survival in weeks and 95%
confidence intervals (CI) are given in column 2 and number of patients in each group in column
3. Variables included in the model (columns 4–5) are prior TMZ and Karnofsky performance
score (KPS).
Variables
Risk Group Median survival (95% CI) n (549) Prior TMZ KPS
Low 52.2 (46.3, 56.9) 108 No ≥ 90
Intermediate 29.3 (25.3, 33.3) 169 No ≤ 80
High 24.4 (22, 28) 272 Yes
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Table 10: partDSABrier(5even) stratification of NABTC patients (Sect. 4) into two risk groups
(column 1: low and high). Corresponding median survival in weeks and 95% confidence intervals
(CI) are given in column 2 and number of patients in each group in column 3. Variables included
in the model (columns 4–10) are Karnofsky performance score (KPS), age, extent of resection
(biopsy (Bx), sub-total (ST), gross total (GT)), time since diagnosis (Dx), prior TMZ, last
known histology (Anaplastic astrocytoma (AA) vs. others), and histological grade (Grade).
Variables
Risk Median survival n Extent of Time Since Prior Last known
Group (95% CI) (549) KPS Age Resect Dx TMZ histology Grade
Low
163 ≤ 55 ≤ 126.6 No III
48.6 ≤ 102.6 Yes AA
(42.3, 59.4) ≤ 55 ST/GT ≤ 126.6 No IV
≥ 90 ≤ 55 ≤ 126.6 No
High
386 > 55 No
26 Yes not AA
(23.7, 29) > 102.6 Yes AA
≤ 80 ≤ 55 > 126.6 No
≤ 55 Bx/ST ≤ 126.6 No IV
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